Insider Trading History of Hassard James

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hassard James since 2021. This trader's CIK number is 1799357. At the time of last reporting, Hassard James was the Chief Commercial Officer of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX). Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..

Note that in the past Hassard James also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) by Hassard James

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 CRNX 0 $0 30,000 $1,331,100 30,000 $591,900

Yearly summary of insider trading at Arrowhead Pharmaceuticals, Inc. (ARWR) by Hassard James

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ARWR 0 $0 19,250 $1,495,297 0 $0


Insider trading activities at 2 companies by Hassard James:

1. Crinetics Pharmaceuticals, Inc. (CRNX)

2. Arrowhead Pharmaceuticals, Inc. (ARWR)

Table 1. Insider trading of Crinetics Pharmaceuticals, Inc. (CRNX) by Hassard James

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-07-05 CRNX Sale 15,000 44.08 661,200
2024-07-05 CRNX Option Ex 15,000 19.73 295,950
2024-06-21 CRNX Sale 15,000 44.66 669,900
2024-06-21 CRNX Option Ex 15,000 19.73 295,950

Table 2. Insider trading of Arrowhead Pharmaceuticals, Inc. (ARWR) by Hassard James

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-06-22 ARWR Sale 3,625 89.22 323,422
2021-01-07 ARWR Sale 15,625 75.00 1,171,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hassard James (Chief Commercial Officer of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.